Dapagliflozin: reduced diabetes incidence in chronic kidney disease? Comments

被引：0
|
作者：
Schwarz, Peter [1 ]
机构：
[1] Univ Klinikum Carl Gustav Carus, Pravent Med Klin 3, Dresden, Germany
来源：
DIABETOLOGIE UND STOFFWECHSEL | 2022年 / 17卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：113 / 114
页数：2
相关论文
共 50 条
  • [1] Dapagliflozin: reduced diabetes incidence in chronic kidney disease?
    Simon, Annika
    [J]. DIABETOLOGIE UND STOFFWECHSEL, 2022, 17 (02)
  • [2] Dapagliflozin and the Incidence of Type 2 Diabetes in Patients with Chronic Kidney Disease
    Rossing, Peter
    Vart, Priya
    Chertow, Glenn M.
    Hou, Fan Fan
    Jongs, Niels
    Mcmurray, John J.
    Correa-Rotter, Ricardo
    Stefansson, Bergur
    Toto, Robert D.
    Langkilde, Anna Maria
    Wheeler, David C.
    Heerspink, Hiddo L.
    [J]. DIABETES, 2021, 70
  • [3] An update on dapagliflozin for chronic kidney disease
    Kelly, Michael S.
    [J]. DRUGS OF TODAY, 2022, 58 (02) : 69 - 75
  • [4] Dapagliflozin for the treatment of chronic kidney disease
    Kurata, Yu
    Nangaku, Masaomi
    [J]. EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2022, 17 (04) : 275 - 291
  • [5] Dapagliflozin (Farxiga) for Chronic Kidney Disease
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2021, 63 (1629): : 115 - 115
  • [6] Dapagliflozin in Patients with Chronic Kidney Disease
    Heerspink, Hiddo J. L.
    Stefansson, Bergur V.
    Correa-Rotter, Ricardo
    Chertow, Glenn M.
    Greene, Tom
    Hou, Fan-Fan
    Mann, Johannes F. E.
    McMurray, John J. V.
    Lindberg, Magnus
    Rossing, Peter
    Sjostrom, C. David
    Toto, Roberto D.
    Langkilde, Anna-Maria
    Wheeler, David C.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (15): : 1436 - 1446
  • [7] Dapagliflozin in Patients with Chronic Kidney Disease
    Yasuda, Hideo
    Isobe, Shinsuke
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (04): : 389 - 389
  • [8] Diabetes and Chronic Kidney Disease in Heart Failure With Reduced and Preserved
    Nichols, Gregory A.
    Qiao, Qing
    Deruaz-Luyet, Anouk
    Kraus, Bettina J.
    [J]. CIRCULATION, 2021, 144
  • [9] Effects of Dapagliflozin in Stage 4 Chronic Kidney Disease
    Chertow, Glenn M.
    Vart, Priya
    Jongs, Niels
    Toto, Robert D.
    Gorriz, Jose Luis
    Hou, Fan Fan
    McMurray, John J. V.
    Correa-Rotter, Ricardo
    Rossing, Peter
    Sjostrom, C. David
    Stefansson, Bergur V.
    Langkilde, Anna Maria
    Wheeler, David C.
    Heerspink, Hiddo J. L.
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (09): : 2352 - 2361
  • [10] Modeling Metformin and Dapagliflozin Pharmacokinetics in Chronic Kidney Disease
    Shahidehpour, Andrew
    Rashid, Mudassir
    Askari, Mohammad Reza
    Ahmadasas, Mohammad
    Abdel-Latif, Mahmoud
    Fritschi, Cynthia
    Quinn, Lauretta
    Reutrakul, Sirimon
    Bronas, Ulf G.
    Cinar, Ali
    [J]. AAPS JOURNAL, 2024, 26 (05):
12345